Vasculitis Screening in Asymptomatic Adults With Positive Family History
No vasculitis-specific screening tests are recommended for an asymptomatic adult solely because a first-degree relative died from vasculitis. (bmj.com) Vasculitis testing should be reserved for patients with clinical findings that create an appropriate pretest probability for vasculitis, since indiscriminate testing in low-pretest settings increases false-positive results without improving diagnostic certainty. (bmj.com)
Screening Laboratory Tests Not Recommended
Routine screening with ANCA testing is not recommended in asymptomatic individuals with low clinical suspicion for ANCA-associated vasculitis. (bmj.com) Routine inflammatory marker testing (eg, ESR and CRP) is not recommended as a vasculitis screening strategy in asymptomatic individuals because these tests lack disease specificity and can be elevated from many nonvasculitic conditions. (bmj.com)
Screening for ANCA-Associated Vasculitis
ANCA testing is advised when clinical suspicion exists for ANCA-associated vasculitis rather than for screening in asymptomatic persons. (ard.bmj.com) A negative ANCA result does not exclude ANCA-associated vasculitis, but this applies in the context of clinical suspicion rather than to population-level screening. (ard.bmj.com)
Screening for Large-Vessel Vasculitis
Large-vessel vasculitis evaluation is symptom-triggered rather than performed as screening in asymptomatic adults. (ard.bmj.com)
Evaluation Approach for Asymptomatic Adults
Clinical assessment should focus on targeted history and physical examination for vasculitis features (eg, constitutional symptoms, organ-specific manifestations) to determine whether testing is warranted. (bmj.com) Testing that is not driven by clinical findings is discouraged because the diagnostic yield depends strongly on pretest probability. (bmj.com)
When Testing Becomes Appropriate
Testing should be initiated when symptoms or signs suggest a specific vasculitis syndrome with sufficient pretest probability to justify diagnostic workup. (bmj.com) Persistent or organ-threatening features should prompt urgent specialty evaluation rather than deferred screening for asymptomatic relatives. (bmj.com)
Common Pitfalls to Avoid
Ordering ANCA testing as a broad screening test in low-pretest-probability settings is discouraged due to low diagnostic certainty and false-positive results. (ouh.nhs.uk)
Targets of Care in Absence of Symptoms
The clinical goal in an asymptomatic individual is not detection of subclinical vasculitis through routine serologic screening. (bmj.com) The clinical goal is recognition of new vasculitis-compatible symptoms that would justify diagnostic testing. (bmj.com)